The Latest Cardiac and Vascular News
Front Line Medical Technologies Article for CardiacVascular News Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an adjunct for Patients Arriving in Cardiac Arrest to the Emergency Room Out-of-hospital cardiac arrest (OHCA) continues to be overwhelmingly fatal despite improvements in Advanced Cardiovascular Life Support (ACLS) protocols and increasing access […]
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in […]
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health Investors and existing investors GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic […]
First of its kind service combines a specialized, multidisciplinary clinical care team with an AI-enabled care management platform for automated medication management, earlier interventions and improved outcomes BOSTON, Feb. 9, 2022 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today the launch of Biofourmis Care, a first of […]
JENA, Germany, Feb. 9, 2022 /PRNewswire/ — Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA is the world’s first and the largest head-to-head RCT investigating the […]
Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Acarix expands its portfolio and submits a breakthrough designation request for its innovative technology for heart failure diagnosis with the Food and Drug Administration (FDA) in USA. Heart failure affects more than 6 million people in the USA at […]
Ethics Committee Approval is Final Step Prior to Enrollment of Claritas’ Phase 1 Clinical Study of R-107 SAN FRANCISCO, CA and TORONTO, ON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today announced that the Australian Human Research Ethics […]
Philips point-of-care ultrasound technology now includes Pulse Wave Doppler for all physicians – from cardiologists and radiologists to emergency care – to quickly assess hemodynamics in cardiac function anytime, anywhere Lumify is also the first and only handheld ultrasound with B-lines software and smart algorithms to enhance heart and lung […]
SLN360, an investigational siRNA to reduce risk of Lp(a)-mediated cardiovascular disease, was safe and well tolerated in the study SLN360 significantly lowered Lp(a) in a dose-dependent manner up to 98% with reductions of up to 81% persisting at 150 days Results to be presented in late breaker at the American […]
Company’s reSept™ ASD Occluder Aims to Evolve Septal Closure with its Novel Metal-Free Frame Design BAAR, Switzerland and SANTA CLARA, Calif., Feb. 8, 2022 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced it has received approval for the start […]
